email

Dear SPORE Directors,

 

With great pleasure, we invite you to the GI SPORE Investigator Meeting. The meeting will be held virtually on November 14-15, 2022, and hosted by the Translational Research Program of the NCI. 

 

The meeting is jointly organized by the Translational Research Program of the NCI together with Dr. Alison Klein and Dr. Laura Beretta.  The meeting will assemble investigators from SPOREs in the following cancer areas: GI, pancreatic, liver, and neuroendocrine.  NCI program staff and SPORE patient advocates with an interest in GI malignancies are invited, guests.  We hope this venue will enable data sharing and that it will offer many new collaborative opportunities within the GI SPORE community.

 

The meeting will address the following four critical areas: (i) cancer immunology, (ii) tumor metabolism, (iii) precursor lesions, early detection and interaction, and (iv) precision therapy.  These sessions will endeavor to develop collaborative approaches to address key questions in the field and define promising scientific areas.

 

Investigators from the seven fully funded SPOREs are asked to contribute 2 Presentations – 15 minutes each with 5 minutes for questions and 1 Junior Investigator Presentation – 12 minutes with 3 mins for questions. Two brand new SPORES are asked to contribute one presentation each to provide an overview of their entire program, plus 7-10 minutes for questions. P20 Cancer Health Disparity (SPORE planning award) grantees with one or more projects in a GI cancer area will be encouraged to contribute one 15-minute presentation.

SPOREs are also asked to consider the diversity of the individuals chosen to speak.  Abstract instructions are included on the meeting website.  All abstracts will be collated into a publicly published abstract book that will be distributed via email initially but will eventually be hosted on the Gi SPORE meeting website (events.cancer.gov/dctd/gisporemeeting). 

 

Please register by November 11, 2022, and submit the abstract by October 28, 2022, on the meeting website at: events.cancer.gov/dctd/gisporemeeting.  Registration and submission questions should be directed to Mia Garrett ([email protected]) or 240-276-6031.

 

Thank you and best regards,

Steve Nothwehr, PhD

National Cancer Institute, DCTD, TRP